TRIBUTE : a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1574231875600790784
  • NII Article ID
    10025555902
  • Data Source
    • CiNii Articles

Report a problem

Back to top